{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:02:23Z","timestamp":1793163743621,"version":"4.5.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009032","name":"Pfizer Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MedCrowd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Antifungal stewardship (AFS) is the judicious use of today\u2019s antifungal agents with the aim of improving patient outcomes and preserving their future effectiveness. Antifungal resistance (AFR) is increasing globally, with more patients at risk of Invasive Fungal Disease (IFD), highlighting the urgent need to standardize AFS practices in the UK. The aim of this position paper is to understand the current AFS landscape in the UK.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A virtual panel discussion was held from September to October 2023 on an online platform followed by a virtual meeting with nine healthcare professionals from across the UK selected for their expertise on IFD management and AFS. The discussion was structured across four topics: current AFS landscape, key elements of an AFS programme, diagnostics and diagnostic stewardship, and unmet needs in education and training. A thematic analysis was carried out. The results represent the collated and summarized views from these activities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results and discussion<\/jats:title>\n                  <jats:p>Participants reported barriers to implementing AFS and its integration within antimicrobial stewardship (AMS) programmes in the UK. The primary challenge identified was a lack of resources, including funding and staff time. Sub-optimal fungal diagnostics and limited mycology expertise was reported as a barrier to AFS, clinical IFD and AFR surveillance. Approaches to combatting these challenges may include investing in formal mycology networks to serve as centres of clinical expertise and diagnostic hubs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>National standards for AFS services and associated outcome metrics need to be established to set a benchmark for centres to improve AFS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlae209","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T07:58:12Z","timestamp":1735631892000},"source":"Crossref","is-referenced-by-count":4,"title":["Antifungal stewardship in the UK: where are we now?"],"prefix":"10.1093","volume":"7","author":[{"given":"Silke","family":"Schelenz","sequence":"first","affiliation":[{"name":"School of Immunology & Microbial Sciences, Kings College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Haemato-Oncology, Barts Health NHS Trust, London, UK"},{"name":"Blizard Institute, Immunobiology, Queen Mary University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Brady","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Queen's University Belfast , Belfast BT9 7BL ,","place":["UK"]},{"name":"Pharmacy Department, Belfast City Hospital, Belfast Health & Social Care Trust , Belfast BT9 7AB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-5151","authenticated-orcid":false,"given":"Gillian","family":"Kiely","sequence":"additional","affiliation":[{"name":"Pfizer Ltd , Speciality Care BU, Tadworth, Surrey ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeshan","family":"Riaz","sequence":"additional","affiliation":[{"name":"Pfizer Ltd , Speciality Care BU, Tadworth, Surrey ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Howes","sequence":"additional","affiliation":[{"name":"Pfizer Ltd , Speciality Care BU, Tadworth, Surrey ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Felton","sequence":"additional","affiliation":[{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne","family":"Micallef","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of East Anglia , Norwich ,","place":["UK"]},{"name":"Pharmacy Department, Cambridge University Hospitals , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netta","family":"Tyler","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Cambridge University Hospitals , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2676-838X","authenticated-orcid":false,"given":"Tihana","family":"Bicanic","sequence":"additional","affiliation":[{"name":"Institute of Infection and Immunity, City St George\u2019s University of London , London SW17 0RE ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Lewis","family":"White","sequence":"additional","affiliation":[{"name":"Public Health Wales Mycology Reference Laboratory, UHW, Heath Park , Cardiff CF14 4XW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"2025022008185369100_dlae209-B1","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025022008185369100_dlae209-B2","article-title":"WHO fungal priority pathogens list to guide research, development and public health action","author":"World Health Organisation","year":"2022."},{"key":"2025022008185369100_dlae209-B3","doi-asserted-by":"publisher","first-page":"dlac055","DOI":"10.1093\/jacamr\/dlac055","article-title":"A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship","volume":"4","author":"Logan","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2025022008185369100_dlae209-B4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"2025022008185369100_dlae209-B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof8010057","article-title":"Trichophyton indotineae\u2014an emerging pathogen causing recalcitrant dermatophytoses in India and worldwide\u2014a multidimensional perspective","volume":"8","author":"Uhrla\u00df","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2025022008185369100_dlae209-B6","author":"English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) Report 2023 to 2024, UK Health Security Agency (UKHSA), 2024"},{"key":"2025022008185369100_dlae209-B7","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3201\/eid2509.190040","article-title":"Epidemiologic shift in Candidemia driven by Candida auris, South Africa, 2016\u20132017(1)","volume":"25","author":"van Schalkwyk","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2025022008185369100_dlae209-B8","article-title":"Promoting antimicrobial stewardship to tackle antimicrobial resistance","author":"World Health Organisation","year":"2024"},{"key":"2025022008185369100_dlae209-B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmi.2018.03.033","article-title":"Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach","volume":"25","author":"Pulcini","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"2025022008185369100_dlae209-B10","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/jac\/dkw390","article-title":"An introduction to antifungal stewardship","volume":"71","author":"Richardson","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2025022008185369100_dlae209-B11","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1099\/jmm.0.000612","article-title":"An investigation of antifungal stewardship programmes in England","volume":"66","author":"Micallef","year":"2017","journal-title":"J Med Microbiol"},{"key":"2025022008185369100_dlae209-B12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jinf.2019.06.009","article-title":"National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: evidence of sub-optimal practice","volume":"79","author":"Schelenz","year":"2019","journal-title":"J Infect"},{"key":"2025022008185369100_dlae209-B13","author":"Whitney"},{"key":"2025022008185369100_dlae209-B14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/antibiotics10020110","article-title":"Assessing the impact of COVID-19 on antimicrobial stewardship activities\/programs in the United Kingdom","volume":"10","author":"Ashiru-Oredope","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2025022008185369100_dlae209-B15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s13054-022-03900-w","article-title":"Impact of COVID-19 pandemic on antifungal consumption: a multicenter retrospective analysis","volume":"26","author":"Bienvenu","year":"2022","journal-title":"Crit Care"},{"key":"2025022008185369100_dlae209-B16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"key":"2025022008185369100_dlae209-B17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7326\/M22-3469","article-title":"Worsening spread of Candida auris in the United States, 2019 to 2021","volume":"176","author":"Lyman","year":"2023","journal-title":"Ann Intern Med"},{"key":"2025022008185369100_dlae209-B18","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/jcm12051912","article-title":"Increasing number of cases due to Candida auris in north Italy, July 2019-December 2022","volume":"12","author":"Sticchi","year":"2023","journal-title":"J Clin Med"},{"issue":"Suppl 3","key":"2025022008185369100_dlae209-B19","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core recommendations for antifungal stewardship: a statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J Infect Dis"},{"key":"2025022008185369100_dlae209-B20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/cid\/ciac623","article-title":"Empiric vs preemptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European Organization for Research and Treatment of Cancer","volume":"76","author":"Maertens","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025022008185369100_dlae209-B21","article-title":"Commissioning for Quality and Innovation (CQUIN) scheme for 2023\/24","author":"NHS England","year":"2024"},{"issue":"Suppl 2","key":"2025022008185369100_dlae209-B22","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025022008185369100_dlae209-B23","article-title":"The Role of Antifungal Stewardship\u2014Online Course","author":"FutureLearn","year":"2024"},{"key":"2025022008185369100_dlae209-B24","article-title":"Massive Open Online Course on Antimicrobial Stewardship","author":"BSAC","year":"2024"},{"key":"2025022008185369100_dlae209-B25","author":"Global Antimicrobial Stewardship Partnership Hub","year":"2024"},{"key":"2025022008185369100_dlae209-B26","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/jac\/dkx493","article-title":"Development and impact of a massive open online course (MOOC) for antimicrobial stewardship","volume":"73","author":"Sneddon","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025022008185369100_dlae209-B27","article-title":"UK Antimicrobial Registry: Collecting real world antimicrobial data, improving patient outcomes, UK Antimicrobial Registry","author":"BSAC","year":"2024"},{"key":"2025022008185369100_dlae209-B28","article-title":"The Antimicrobial Products Subscription Model: consultation on proposals","author":"NHS England","year":"2024"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/1\/dlae209\/61297981\/dlae209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/1\/dlae209\/61297981\/dlae209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:20:49Z","timestamp":1740039649000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlae209\/7935031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlae209","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,12,26]]},"article-number":"dlae209"}}